Home › Kanser sa Pantog › Washington › Seattle
Pag-aaral pangklinika para sa Kanser sa Pantog sa Seattle, WA
Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Nagre-recruitPhase 3
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- at 1 pa
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Nagre-recruitPhase 2
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Nagre-recruitPhase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Nagre-recruitObservasyonal na pag-aaral
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- at 3 pa
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Nagre-recruitPhase 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Nagre-recruitPhase 2
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- Swedish Cancer Institute, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Nagre-recruit
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
Nagre-recruitPhase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Nagre-recruitPhase 2/3
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- University of Washington School of Medicine, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Nagre-recruitPhase 2
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Nagre-recruitPhase 3
- Research Site, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Nagre-recruitPhase 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Nagre-recruit
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
Blue Light Cystoscopy With Cysview® Registry
Nagre-recruitObservasyonal na pag-aaral
- University of Washington Medicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Seattle
Pag-aaral para sa Kanser sa Pantog sa ibang lungsod
- New York City, NY36 pag-aaral
- Nashville, TN31 pag-aaral
- Houston, TX31 pag-aaral
- Dallas, TX27 pag-aaral
- Boston, MA26 pag-aaral
- Washington, DC26 pag-aaral
- Los Angeles, CA25 pag-aaral
- Baltimore, MD24 pag-aaral
- Philadelphia, PA23 pag-aaral
- Edison, NJ23 pag-aaral
- St. Louis, MO22 pag-aaral
- Chicago, IL21 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser (lahat ng uri)48 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Metastatic Cancer39 pag-aaral
- Kanser sa Suso37 pag-aaral
- Colorectal Cancer35 pag-aaral
- Kanser sa Baga34 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Acute Lymphoblastic Leukemia22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.